Smith & Nephew PLC SN.L

GBX1,193.00 GBX6.50 (0.54%) 1D

Last Updated: Mar 27, 12:00 AM·LSE

SN.L Shariah Compliance

Screening Methodology: AAOIFI

lock image
UNLOCK FOR FREE

Last Updated: March 23, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Smith & Nephew PLC (SN.L)

Based on 24 analysts giving stock ratings to Smith & Nephew PLC in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
29
Buy
25
Hold
42
Sell
4
Strong Sell
0
Smith & Nephew PLC

Smith & Nephew PLC. Stock Analysis SN.L

United Kingdom Health Care Large Cap Report:
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 17,000 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Read More

Smith & Nephew PLC (SN.L) Chart

Key Statistics of Smith & Nephew PLC (SN.L)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

GBX1,189.50GBX1,207.50

Today's Open

GBX1,199.50

Volume

1.15M

P/E Ratio (TTM)

21.93

52 Week Range

GBX937.80GBX1,441.50

Market Cap

1.05T

Avg. Volume

1.71M

Dividend Yield

2.41%

Financial Metrics & Statements of Smith & Nephew PLC (SN.L)

FAQ's for Smith & Nephew PLC (SN.L)

  • According to Musaffa’s Shariah screening methodology, Smith & Nephew PLC (SN.L) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.